Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene

J. D. Buxbaum, L. Georgieva, J. J. Young, C. Plescia, Y. Kajiwara, Y. Jiang, V. Moskvina, Nadine Norton, T. Peirce, H. Williams, N. J. Craddock, L. Carroll, G. Corfas, K. L. Davis, M. J. Owen, S. Harroch, T. Sakurai, M. C. O'Donovan

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Neuregulin and the neuregulin receptor ERBB4 have been genetically and functionally implicated in schizophrenia. In this study, we used the yeast two-hybrid system to identify proteins that interact with ERBB4, to identify genes and pathways that might contribute to schizophrenia susceptibility. We identified the MAGI scaffolding proteins as ERBB4-binding proteins. After validating the interaction of MAGI proteins with ERBB4 in mammalian cells, we demonstrated that ERBB4 expression, alone or in combination with ERBB2 or ERBB3, led to the tyrosine phosphorylation of MAGI proteins, and that this could be further enhanced with receptor activation by neuregulin. As MAGI proteins were previously shown to interact with receptor phosphotyrosine phosphatase β/ζ (RPTPβ), we postulated that simultaneous binding of MAGI proteins to RPTPβ and ERBB4 forms a phosphotyrosine kinase/phosphotyrosine phosphatase complex. Studies in cultured cells confirmed both a spatial and functional association between ERBB4, MAGI and RPTPβ. Given the evidence for this functional association, we examined the genes coding for MAGI and RPTPβ for genetic association with schizophrenia in a Caucasian United Kingdom case-control cohort (n=∼1400). PTPRZ1, which codes for RPTPβ, showed significant, gene-wide and hypothesis-wide association with schizophrenia in our study (best individual single-nucleotide polymorphism allelic P=0.0003; gene-wide P=0.0064; hypothesis-wide P=0.026). The data provide evidence for a role of PTPRZ1, and for RPTPβ signaling abnormalities, in the etiology of schizophrenia. Furthermore, the data indicate a role for RPTPβ in the modulation of ERBB4 signaling that may in turn provide further support for an important role of neuregulin/ERBB4 signaling in the molecular basis of schizophrenia.

Original languageEnglish (US)
Pages (from-to)162-172
Number of pages11
JournalMolecular Psychiatry
Volume13
Issue number2
DOIs
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Protein Tyrosine Phosphatases
Dissection
Schizophrenia
Neuregulins
Genes
Proteins
Carrier Proteins
Two-Hybrid System Techniques
Phosphotyrosine
Single Nucleotide Polymorphism
Tyrosine
Cultured Cells
Phosphotransferases
Phosphorylation

Keywords

  • Association
  • Case-control studies
  • ERBB4
  • Neuregulins
  • Protein-tyrosine-phosphatase
  • Receptor protein-tyrosine kinases

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health

Cite this

Buxbaum, J. D., Georgieva, L., Young, J. J., Plescia, C., Kajiwara, Y., Jiang, Y., ... O'Donovan, M. C. (2008). Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Molecular Psychiatry, 13(2), 162-172. https://doi.org/10.1038/sj.mp.4001991

Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. / Buxbaum, J. D.; Georgieva, L.; Young, J. J.; Plescia, C.; Kajiwara, Y.; Jiang, Y.; Moskvina, V.; Norton, Nadine; Peirce, T.; Williams, H.; Craddock, N. J.; Carroll, L.; Corfas, G.; Davis, K. L.; Owen, M. J.; Harroch, S.; Sakurai, T.; O'Donovan, M. C.

In: Molecular Psychiatry, Vol. 13, No. 2, 02.2008, p. 162-172.

Research output: Contribution to journalArticle

Buxbaum, JD, Georgieva, L, Young, JJ, Plescia, C, Kajiwara, Y, Jiang, Y, Moskvina, V, Norton, N, Peirce, T, Williams, H, Craddock, NJ, Carroll, L, Corfas, G, Davis, KL, Owen, MJ, Harroch, S, Sakurai, T & O'Donovan, MC 2008, 'Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene', Molecular Psychiatry, vol. 13, no. 2, pp. 162-172. https://doi.org/10.1038/sj.mp.4001991
Buxbaum, J. D. ; Georgieva, L. ; Young, J. J. ; Plescia, C. ; Kajiwara, Y. ; Jiang, Y. ; Moskvina, V. ; Norton, Nadine ; Peirce, T. ; Williams, H. ; Craddock, N. J. ; Carroll, L. ; Corfas, G. ; Davis, K. L. ; Owen, M. J. ; Harroch, S. ; Sakurai, T. ; O'Donovan, M. C. / Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. In: Molecular Psychiatry. 2008 ; Vol. 13, No. 2. pp. 162-172.
@article{873bf85603d142509e81fb6ac523bb5b,
title = "Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene",
abstract = "Neuregulin and the neuregulin receptor ERBB4 have been genetically and functionally implicated in schizophrenia. In this study, we used the yeast two-hybrid system to identify proteins that interact with ERBB4, to identify genes and pathways that might contribute to schizophrenia susceptibility. We identified the MAGI scaffolding proteins as ERBB4-binding proteins. After validating the interaction of MAGI proteins with ERBB4 in mammalian cells, we demonstrated that ERBB4 expression, alone or in combination with ERBB2 or ERBB3, led to the tyrosine phosphorylation of MAGI proteins, and that this could be further enhanced with receptor activation by neuregulin. As MAGI proteins were previously shown to interact with receptor phosphotyrosine phosphatase β/ζ (RPTPβ), we postulated that simultaneous binding of MAGI proteins to RPTPβ and ERBB4 forms a phosphotyrosine kinase/phosphotyrosine phosphatase complex. Studies in cultured cells confirmed both a spatial and functional association between ERBB4, MAGI and RPTPβ. Given the evidence for this functional association, we examined the genes coding for MAGI and RPTPβ for genetic association with schizophrenia in a Caucasian United Kingdom case-control cohort (n=∼1400). PTPRZ1, which codes for RPTPβ, showed significant, gene-wide and hypothesis-wide association with schizophrenia in our study (best individual single-nucleotide polymorphism allelic P=0.0003; gene-wide P=0.0064; hypothesis-wide P=0.026). The data provide evidence for a role of PTPRZ1, and for RPTPβ signaling abnormalities, in the etiology of schizophrenia. Furthermore, the data indicate a role for RPTPβ in the modulation of ERBB4 signaling that may in turn provide further support for an important role of neuregulin/ERBB4 signaling in the molecular basis of schizophrenia.",
keywords = "Association, Case-control studies, ERBB4, Neuregulins, Protein-tyrosine-phosphatase, Receptor protein-tyrosine kinases",
author = "Buxbaum, {J. D.} and L. Georgieva and Young, {J. J.} and C. Plescia and Y. Kajiwara and Y. Jiang and V. Moskvina and Nadine Norton and T. Peirce and H. Williams and Craddock, {N. J.} and L. Carroll and G. Corfas and Davis, {K. L.} and Owen, {M. J.} and S. Harroch and T. Sakurai and O'Donovan, {M. C.}",
year = "2008",
month = "2",
doi = "10.1038/sj.mp.4001991",
language = "English (US)",
volume = "13",
pages = "162--172",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene

AU - Buxbaum, J. D.

AU - Georgieva, L.

AU - Young, J. J.

AU - Plescia, C.

AU - Kajiwara, Y.

AU - Jiang, Y.

AU - Moskvina, V.

AU - Norton, Nadine

AU - Peirce, T.

AU - Williams, H.

AU - Craddock, N. J.

AU - Carroll, L.

AU - Corfas, G.

AU - Davis, K. L.

AU - Owen, M. J.

AU - Harroch, S.

AU - Sakurai, T.

AU - O'Donovan, M. C.

PY - 2008/2

Y1 - 2008/2

N2 - Neuregulin and the neuregulin receptor ERBB4 have been genetically and functionally implicated in schizophrenia. In this study, we used the yeast two-hybrid system to identify proteins that interact with ERBB4, to identify genes and pathways that might contribute to schizophrenia susceptibility. We identified the MAGI scaffolding proteins as ERBB4-binding proteins. After validating the interaction of MAGI proteins with ERBB4 in mammalian cells, we demonstrated that ERBB4 expression, alone or in combination with ERBB2 or ERBB3, led to the tyrosine phosphorylation of MAGI proteins, and that this could be further enhanced with receptor activation by neuregulin. As MAGI proteins were previously shown to interact with receptor phosphotyrosine phosphatase β/ζ (RPTPβ), we postulated that simultaneous binding of MAGI proteins to RPTPβ and ERBB4 forms a phosphotyrosine kinase/phosphotyrosine phosphatase complex. Studies in cultured cells confirmed both a spatial and functional association between ERBB4, MAGI and RPTPβ. Given the evidence for this functional association, we examined the genes coding for MAGI and RPTPβ for genetic association with schizophrenia in a Caucasian United Kingdom case-control cohort (n=∼1400). PTPRZ1, which codes for RPTPβ, showed significant, gene-wide and hypothesis-wide association with schizophrenia in our study (best individual single-nucleotide polymorphism allelic P=0.0003; gene-wide P=0.0064; hypothesis-wide P=0.026). The data provide evidence for a role of PTPRZ1, and for RPTPβ signaling abnormalities, in the etiology of schizophrenia. Furthermore, the data indicate a role for RPTPβ in the modulation of ERBB4 signaling that may in turn provide further support for an important role of neuregulin/ERBB4 signaling in the molecular basis of schizophrenia.

AB - Neuregulin and the neuregulin receptor ERBB4 have been genetically and functionally implicated in schizophrenia. In this study, we used the yeast two-hybrid system to identify proteins that interact with ERBB4, to identify genes and pathways that might contribute to schizophrenia susceptibility. We identified the MAGI scaffolding proteins as ERBB4-binding proteins. After validating the interaction of MAGI proteins with ERBB4 in mammalian cells, we demonstrated that ERBB4 expression, alone or in combination with ERBB2 or ERBB3, led to the tyrosine phosphorylation of MAGI proteins, and that this could be further enhanced with receptor activation by neuregulin. As MAGI proteins were previously shown to interact with receptor phosphotyrosine phosphatase β/ζ (RPTPβ), we postulated that simultaneous binding of MAGI proteins to RPTPβ and ERBB4 forms a phosphotyrosine kinase/phosphotyrosine phosphatase complex. Studies in cultured cells confirmed both a spatial and functional association between ERBB4, MAGI and RPTPβ. Given the evidence for this functional association, we examined the genes coding for MAGI and RPTPβ for genetic association with schizophrenia in a Caucasian United Kingdom case-control cohort (n=∼1400). PTPRZ1, which codes for RPTPβ, showed significant, gene-wide and hypothesis-wide association with schizophrenia in our study (best individual single-nucleotide polymorphism allelic P=0.0003; gene-wide P=0.0064; hypothesis-wide P=0.026). The data provide evidence for a role of PTPRZ1, and for RPTPβ signaling abnormalities, in the etiology of schizophrenia. Furthermore, the data indicate a role for RPTPβ in the modulation of ERBB4 signaling that may in turn provide further support for an important role of neuregulin/ERBB4 signaling in the molecular basis of schizophrenia.

KW - Association

KW - Case-control studies

KW - ERBB4

KW - Neuregulins

KW - Protein-tyrosine-phosphatase

KW - Receptor protein-tyrosine kinases

UR - http://www.scopus.com/inward/record.url?scp=38349111686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349111686&partnerID=8YFLogxK

U2 - 10.1038/sj.mp.4001991

DO - 10.1038/sj.mp.4001991

M3 - Article

VL - 13

SP - 162

EP - 172

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 2

ER -